A scientific team from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and Mo...
The Biomedical Sciences industry, which comprises the biopharmaceutical and medical technology sectors, is a key contrib...
Synapxe, Singapore's national HealthTech agency, has launched HEALIX, the platform for Health Empowerment thru...
Themed "Driving Innovation, Nurturing Talents: Creating Impact for Asia", InnovFest x Elevating Founders 2024&nbs...
A randomised, placebo-controlled clinical trial led by a collaboration between Duke-NUS Medical School, National Heart C...
Singapore's Ministry of Health has announced that Novavax/Nuvaxovid XBB.1.5 COVID-19 vaccine will be available under the...
Nanyang Technological University (NTU) Singapore is deepening its partnership with Kazakhstan with a new collaboration t...
Two multi-institution and multidisciplinary Singapore teams of clinician-scientists and researchers have been awarded gr...
Researchers from Duke-NUS Medical School in Singapore have found that a new class of light-sensitive proteins are capabl...
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies ...
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovat...
British multinational pharmaceutical company AstraZeneca intends to build a $1.5 billion manufacturing facilit...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...
As Asia establishes itself as the global hub for clinical trials, Singapore is bolstering its position as the preferred ...
The National University Hospital (NUH) and Mirxes have announced the official opening of the NUH DMOC@Biopolis, one of S...
Bijay Singh, Global Head, Business Unit Healthcare, DKSH Emerging trends in healthcare are demonstrating profound chang...
GSK's Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for...
Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...
